No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan
- Author
- LIU, Rue-Tsuan1 ; CHEN, Yi-Ju2 ; CHOU, Fong-Fu3 ; LI, Chun-Liang4 ; WU, Wei-Li1 ; TSAI, Po-Chin4 ; HUANG, Chao-Cheng2 ; CHENG, Jiin-Tsuey4
[1] Division of Metabolism, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Province of China
[2] Department of Pathology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Province of China
[3] Department of Surgery, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Province of China
[4] Department of Biological Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan, Province of China - Source
Clinical endocrinology (Oxford. Print). 2005, Vol 63, Num 4, pp 461-466, 6 p ; ref : 40 ref
- CODEN
- CLECAP
- ISSN
- 0300-0664
- Scientific domain
- Endocrinology
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Cancer thyroïde Carcinome papillaire Endocrinologie Génétique Mutation Carcinome thyroïde Taiwan Endocrinopathie Thyroïde pathologie Tumeur maligne Asie
- Keyword (en)
- Thyroid cancer Papillary carcinoma Endocrinology Genetics Mutation Thyroid carcinoma Taiwan Endocrinopathy Thyroid diseases Malignant tumor Asia
- Keyword (es)
- Cáncer de la tiroides Carcinoma papilar Endocrinología Genética Mutación Carcinoma tiroides Taiwan Endocrinopatía Tiroides patología Tumor maligno Asia
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A28 Vertebrates: endocrinology
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21C Thyroid. Thyroid axis (diseases) / 002B21C02 Malignant tumors
- Discipline
- Endocrinopathies Vertebrates : endocrinology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17130985
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1365-2265.2005.02367.x 
https://dx.doi.org/10.1111/j.1365-2265.2005.02367.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2265.2005.02367.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Clinical endocrinology (Oxford. Print)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Clin. endocrinol. (Oxf., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"461\";s:8:\"\u0000*\u0000epage\";s:3:\"466\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0300-0664\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIU\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rue-Tsuan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Yi-Ju\";i:1;s:13:\"CHOU, Fong-Fu\";i:2;s:14:\"LI, Chun-Liang\";i:3;s:10:\"WU, Wei-Li\";i:4;s:13:\"TSAI, Po-Chin\";i:5;s:17:\"HUANG, Chao-Cheng\";i:6;s:17:\"CHENG, Jiin-Tsuey\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLECAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2265.2005.02367.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Clinical endocrinology (Oxford. Print)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Clin. endocrinol. (Oxf., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"461\";s:8:\"\u0000*\u0000epage\";s:3:\"466\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0300-0664\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIU\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rue-Tsuan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Yi-Ju\";i:1;s:13:\"CHOU, Fong-Fu\";i:2;s:14:\"LI, Chun-Liang\";i:3;s:10:\"WU, Wei-Li\";i:4;s:13:\"TSAI, Po-Chin\";i:5;s:17:\"HUANG, Chao-Cheng\";i:6;s:17:\"CHENG, Jiin-Tsuey\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLECAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2265.2005.02367.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2265.2005.02367.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Clinical endocrinology (Oxford. Print)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Clin. endocrinol. (Oxf., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"461\";s:8:\"\u0000*\u0000epage\";s:3:\"466\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0300-0664\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIU\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rue-Tsuan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Yi-Ju\";i:1;s:13:\"CHOU, Fong-Fu\";i:2;s:14:\"LI, Chun-Liang\";i:3;s:10:\"WU, Wei-Li\";i:4;s:13:\"TSAI, Po-Chin\";i:5;s:17:\"HUANG, Chao-Cheng\";i:6;s:17:\"CHENG, Jiin-Tsuey\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLECAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2265.2005.02367.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Clinical endocrinology (Oxford. Print)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Clin. endocrinol. (Oxf., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"461\";s:8:\"\u0000*\u0000epage\";s:3:\"466\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0300-0664\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIU\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rue-Tsuan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Yi-Ju\";i:1;s:13:\"CHOU, Fong-Fu\";i:2;s:14:\"LI, Chun-Liang\";i:3;s:10:\"WU, Wei-Li\";i:4;s:13:\"TSAI, Po-Chin\";i:5;s:17:\"HUANG, Chao-Cheng\";i:6;s:17:\"CHENG, Jiin-Tsuey\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLECAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1365-2265.2005.02367.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Clinical endocrinology (Oxford. Print)\";s:9:\"\u0000*\u0000stitle\";s:31:\"Clin. endocrinol. (Oxf., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"461\";s:8:\"\u0000*\u0000epage\";s:3:\"466\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0300-0664\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIU\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Rue-Tsuan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Yi-Ju\";i:1;s:13:\"CHOU, Fong-Fu\";i:2;s:14:\"LI, Chun-Liang\";i:3;s:10:\"WU, Wei-Li\";i:4;s:13:\"TSAI, Po-Chin\";i:5;s:17:\"HUANG, Chao-Cheng\";i:6;s:17:\"CHENG, Jiin-Tsuey\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CLECAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:116:\"No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
